Navigation Links
Osteotech Signs Agreement To Distribute Harvest Technologies' BMAC(TM) System
Date:3/4/2008

EATONTOWN, N.J., March 4 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic solutions for regenerative medicine, announced today that it has entered into a three-year agreement with Harvest Technologies Corporation to distribute the BMAC(TM) (Bone Marrow Aspirate Concentrate) System. Under the agreement, Osteotech has the exclusive right to distribute the BMAC(TM) System for bone regeneration in orthopedic and spinal surgical procedures in most of the United States.

Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer, stated, "Osteotech is very excited to partner with Harvest for the distribution of the BMAC(TM) System. We believe Harvest's proprietary BMAC(TM) System will complement Osteotech's proprietary technologies in Biocomposite, which includes the Plexur P(TM) and Plexur M(TM), and DBM, furthering Osteotech's regenerative healing equation - Matrix + Signal + Cell."

Mr. Owusu-Akyaw concluded, "We expect to begin to distribute the BMAC(TM) System before the end of the second quarter of 2008. We are currently putting the finishing touches on our roll-out plan and will begin training our sales team shortly. In conjunction with Harvest, we will introduce the BMAC(TM) System at the American Academy of Orthopedic Surgeons 2008 Annual Meeting, March 5 through 7, 2008, in San Francisco, California."

The BMAC(TM) System, developed and manufactured by Harvest, is the first "point-of-care" platform that makes possible the use of a clinically significant quantity of cellular compositions from a small aspirate of bone marrow. The BMAC(TM) System derives bone marrow aspirate concentrate, which is a rich source of autologous adult stem cells, in just 15 minutes.

Harvest, a privately held company based in Plymouth, Massachusetts, has a rich tradition of innovative technologies that are designed to process and concentrate autologous cells and proteins. The BMAC(TM) System incorporates a proprietary floating shelf technology which provides the highest mononuclear cell yield with enhanced viability, osteogenicity and angiogenesis in both animal and in-vitro testing.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech or this press release, please go to Osteotech's website at http://www.osteotech.com.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of March 4, 2008 and the Company does not intend to update this information.


'/>"/>
SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
2. Osteotech Completes Tissue Supply Agreement With LifeNet Health
3. Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09
5. Pot bellies linked to early signs of cardiovascular disease
6. MSU engineering team designs innovative medical device
7. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
8. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
9. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
10. A new technology for cancer screening listens for the signs of cancer
11. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... (PRWEB) , ... January 22, 2017 , ... Zifam Pinnacle, ... across the world, recently met with big-name retail buyers at the January ECRM Trade ... of efficacy and uses the utmost safety standards in all of its creations to ...
(Date:1/21/2017)... ... ... perfect set of tools for video editors that want to create the illusion of rack ... of Pixel Film Studios. , Video editors using ProDOF can add realistic depth of ... from one area into the next. ProDOF comes with 0.5 second, 1.0 second, 1.5 ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) is ... at 167 Lynch Creek Way. The Petaluma office features three comfortable patient exam ... rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. Neema ...
(Date:1/20/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh has posted a new publication ... this generation is a time like no other and society needs to understand the only ... he does not want to sound like an old bible beater because religion has a ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an ... lives, recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting ... its large range of supplements that keep the body functioning at its peak ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... DIEGO , 23 janvier 2017  ResMed (NYSE : ... Haven , Floride) ont annoncé aujourd,hui qu,ils se sont ... litiges existants entre les parties. BMC et 3B seront ... paiements de droits à ResMed, et ResMed effectuera le ... 3B pour clore le litige de Floride entre les ...
(Date:1/23/2017)... InDex Pharmaceuticals Holding AB (publ) today announced that the company ... Crohn,s and Colitis Organisation (ECCO). The ECCO congress is the largest ... disease (IBD). The congress is held in Barcelona, Spain ... ... selected to present data at the largest IBD congress in the ...
(Date:1/21/2017)... (NYSE: RMD ), BMC ( Beijing, China ... today announced they have agreed on a global settlement of all ... sell their existing products in exchange for royalty payments to ResMed, ... close the Florida litigation between the two ... wrongdoing by any party. The five-year agreement between ...
Breaking Medicine Technology: